Company record
PROQR THERAPEUTICS II B.V.
- B.V.
Signals
7 on record
- EPO patentsPatent
Patent publication AU2025262720A1 by PROQR THERAPEUTICS II B.V.: ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF FATTY LIVER DISEASE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication AU2025254945A1 by PROQR THERAPEUTICS II B.V.: ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF POLY-Q DISEASE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication US20260347845A1 by ProQR Therapeutics II B.V.: ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication EP4828986A1 by ProQR Therapeutics II B.V.: ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF HUNTINGTON'S DISEASE.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication US20260327622A1 by ProQR Therapeutics II B.V.: DELIVERY OF OLIGONUCLEOTIDES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026215389A1 by PROQR THERAPEUTICS II B.V.: SAPONIN DERIVATIVES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026202062A1 by PROQR THERAPEUTICS II B.V.: ANTISENSE OLIGONUCLEOTIDES.
EPO patentsRelevance21
Watch · 80% confidence